Bengaluru

Arnya RealEstates Fund Advisors has committed Rs 130 crore to Casagrand’s upcoming residential project in South Bengaluru, marking the second investment for the company. This investment follows its first foray in October 2024, which targeted a project in Navi Mumbai. Arnya’s debut fund, the Arnya Real Estate Fund - Debt, launched in April 2024, has a target corpus of Rs 1,000 crore, with a green shoe option of an additional Rs 1,000 crore.

India's commercial real estate sector is demonstrating robust momentum in 2024, as office rents in seven major Indian cities recorded a year-on-year increase between 4% and 8%. This stands in contrast to global markets such as New York, Shanghai, and Hong Kong, where rental rates have declined. According to new data, rising business activity and corporate expansions have intensified demand for office spaces across India. Meanwhile, international cities grapple with the disruptive impact of remote work, generative AI, and evolving workplace models.

OneSource Specialty Pharma has achieved a significant regulatory milestone with its flagship manufacturing unit in Bengaluru receiving Good Manufacturing Practices (GMP) certification from ANVISA, Brazil’s premier health authority. The approval follows a successful inspection conducted in November 2024 and positions the company to expand into one of the world’s largest pharmaceutical markets. This development is especially timely as Brazil prepares to welcome generic versions of Semaglutide, a blockbuster drug category.

Juspay, the Bengaluru-based payments company, has secured USD 60 million (approximately Rs. 514 crore) in a Series D funding round led by Kedaara Capital. Existing investors, including Softbank and Accel, also participated in this round. The company plans to use the funds to enhance its artificial intelligence (AI) capabilities, focusing on developing future-ready innovations that aim to boost workforce productivity and improve the overall merchant experience.